Analystreport

Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.

Krystal Biotech, Inc.  (KRYS) 
Last krystal biotech, inc. earnings: 11/4 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.krystalbio.com/investors